Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in September 

On August 20, 2018 Coherus BioSciences, Inc. (Nasdaq: CHRS), reported that senior management will participate in two upcoming investor healthcare conferences in September (Press release, Coherus Biosciences, AUG 20, 2018, View Source;p=RssLanding&cat=news&id=2364115 [SID1234529052]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management participation in a fireside chat is scheduled at Baird’s 2018 Global Healthcare Conference on Wednesday, September 5th at 10:50 a.m. ET taking place in New York, NY. Management participation in a fireside chat is scheduled at the 13th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 6th at 8:00 a.m. ET taking place in Boston, MA.

The audio portion of the presentations will be available on the investors page of the Coherus BioSciences website at View Source